Promoter analysis of the BRMS1 gene indicated that epigenetic silencing contributes to the reduction or loss of BRMS1 expression in breast carcinoma and non-small-cell lung cancer [38], [39]. This evidence concerns the gene BRMS1 and breast carcinoma.